Stay updated on Bortezomib vs Carfilzomib in Newly Diagnosed Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Bortezomib vs Carfilzomib in Newly Diagnosed Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Bortezomib vs Carfilzomib in Newly Diagnosed Multiple Myeloma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.5.3 to v3.5.4, signaling a new release version of the page. This reflects a background update to the site's text and structure without changing the study details.
    Difference
    0.1%
    Check dated 2026-05-15T04:22:43.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.2 to v3.5.3, indicating a small version update that does not modify study details or user-facing information.
    Difference
    0.1%
    Check dated 2026-04-30T17:29:28.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    A new revision entry v3.5.2 was added and the v3.5.0 revision was removed from the record history.
    Difference
    0.1%
    Check dated 2026-04-16T10:38:42.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-18T17:58:08.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2 from the page history. This appears to be a UI/site version update and does not modify trial data or study contents.
    Difference
    0.1%
    Check dated 2026-03-11T16:42:35.000Z thumbnail image
  9. Check
    108 days ago
    Change Detected
    Summary
    Added a new revision entry: v3.4.2; removed the funding-lapse notice and an older revision entry (v3.4.1).
    Difference
    0.7%
    Check dated 2026-02-11T02:04:48.000Z thumbnail image

Stay in the know with updates to Bortezomib vs Carfilzomib in Newly Diagnosed Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Bortezomib vs Carfilzomib in Newly Diagnosed Multiple Myeloma Clinical Trial page.